{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T17:28:07Z","timestamp":1762622887604},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2004,8,31]],"date-time":"2004-08-31T00:00:00Z","timestamp":1093910400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,8,31]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>The immunological diagnosis and development of new antituberculosis vaccines require the characterization of Mycobacterium tuberculosis antigens inducing cell-mediated immune responses. In this study, we have tested peripheral blood mononuclear cells (PBMC) from tuberculosis (TB) patients (n = 43) and Bacille Calmette\u2013Gu\u00e9rin (BCG)-vaccinated healthy subjects (n = 24) for in vitro cellular immune responses, as indicated by antigen-induced proliferation and interferon (IFN)-\u03b3 secretion, in response to a panel of complex (culture filtrate and cell wall preparations) and single recombinant antigens (Mtb8.4, Mtb9.8, Mtb9.9, Mtb32A, Mtb39A, Mtb40, Mtb41 and Ag85B) of M. tuberculosis. The results of cellular responses showed that the majority (ranging from 70 to 98%) of TB patients and healthy donors responded to the complex antigens in antigen-induced proliferation and IFN-\u03b3 secretion assays. However, when PBMC from the same groups of patients and healthy donors were tested with the recombinant antigens, TB patients showed strong recognition (&amp;gt;50% responders) of Mtb9.8 and Mtb39A in proliferation assays (median SI = 6.2 and 6.4, respectively) and of Mtb9.8, Mtb39A, Mtb40 and Ag85B in IFN-\u03b3 assays (median delta IFN-\u03b3=\u200315.5, 10.8, 7.8 and 8.1\u2003U\/ml, respectively). BCG-vaccinated healthy donors showed weak (&amp;lt;30% responders) to moderate (31\u201350% responders) responses to all of the recombinant antigens in both assays. When PBMC of a subset of TB patients (n = 11) were tested for secretion of protective Th1 cytokines [IFN-\u03b3, tumour necrosis factor (TNF)-\u03b1 and interleukin (IL)-12] and the immunosuppressive cytokine IL-10, the complex CF and CW antigens as well as the recombinant Mtb9.8, Mtb9.9, Mtb40 and Ag85B induced the secretion of both types of cytokines. On the other hand, Mtb41 induced only IL-10, while Mtb8.4, Mtb32Aand Mtb39A induced the secretion of one or more of Th1 cytokines, but not IL-10. In conclusion, the recombinant antigens inducing the secretion of Th1 cytokines could be useful as subunit vaccine candidates against TB.<\/jats:p>","DOI":"10.1111\/j.1365-2249.2004.02609.x","type":"journal-article","created":{"date-parts":[[2004,9,16]],"date-time":"2004-09-16T13:49:46Z","timestamp":1095342586000},"page":"139-144","source":"Crossref","is-referenced-by-count":41,"title":["<i>In vitro<\/i>cellular immune responses to complex and newly defined recombinant antigens of<i>Mycobacterium tuberculosis<\/i>"],"prefix":"10.1093","volume":"138","author":[{"given":"R","family":"AL-ATTIYAH","sequence":"first","affiliation":[{"name":"Departments of Microbiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A S","family":"MUSTAFA","sequence":"additional","affiliation":[{"name":"Departments of Microbiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A T","family":"ABAL","sequence":"additional","affiliation":[{"name":"Medicine, Faculty of Medicine, Kuwait University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A S M","family":"EL-SHAMY","sequence":"additional","affiliation":[{"name":"Chest Diseases Hospital, Ministry of Health, Kuwait"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W","family":"DALEMANS","sequence":"additional","affiliation":[{"name":"GlaxoSmithKline Biologicals, Rixensart, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y A W","family":"SKEIKY","sequence":"additional","affiliation":[{"name":"Corixa Corporation, Seattle, Washington, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2004,8,31]]},"reference":[{"key":"2022010901425794600_b1","first-page":"391","article-title":"Tuberculosis","volume-title":"Topley and Wilson's microbiology and microbial infections","author":"Grange","year":"1998"},{"key":"2022010901425794600_b2","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0140-6736(03)14333-4","article-title":"Tuberculosis","volume":"362","author":"Frieden","year":"2003","journal-title":"Lancet"},{"key":"2022010901425794600_b3","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1086\/514132","article-title":"The immune response in human tuberculosis \u2212 implications for tuberculosis control","volume":"176","author":"Ellner","year":"1997","journal-title":"J Infect Dis"},{"key":"2022010901425794600_b4","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1086\/513642","article-title":"Disseminated bacilli Calmette\u2013Guerin disease after vaccination: case report and review","volume":"24","author":"Talbot","year":"1997","journal-title":"Clin Infect Dis"},{"key":"2022010901425794600_b5","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1159\/000237172","article-title":"Vaccination against tuberculosis","volume":"108","author":"Lowrie","year":"1995","journal-title":"Int Arch Allergy Immunol"},{"key":"2022010901425794600_b6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2174\/1389201013378707","article-title":"Biotechnology in the development of new vaccines and diagnostic reagents against tuberculosis","volume":"2","author":"Mustafa","year":"2001","journal-title":"Curr Pharmaceut Biotechnol"},{"key":"2022010901425794600_b7","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0161-5890(02)00048-2","article-title":"Development of new vaccines and diagnostic reagents against tuberculosis","volume":"39","author":"Mustafa","year":"2002","journal-title":"Mol Immunol"},{"key":"2022010901425794600_b8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.0300-9475.2004.01349.x","article-title":"Computer-assisted prediction of HLA-DR binding and experimental analysis of human promiscuous Th1-cell peptides in the 24-kDA secreted lipoprotein (LPPX) of Mycobacterium tuberculosis","volume":"59","author":"Al-Attiyah","year":"2003","journal-title":"Scand J Immunol"},{"key":"2022010901425794600_b9","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.4049\/jimmunol.161.5.2356","article-title":"Molecular cloning and immunologic reactivity of a novel low molecular mass antigen of Mycobacterium tuberculosis","volume":"161","author":"Coler","year":"1998","journal-title":"J Immunol"},{"key":"2022010901425794600_b10","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1128\/IAI.67.6.2941-2950.1999","article-title":"Molecular characterization and human T-cell responses to a member of a novel Mycobacterium tuberculosis mtb39 gene family","volume":"67","author":"Dillon","year":"1999","journal-title":"Infect Immun"},{"key":"2022010901425794600_b11","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1128\/IAI.67.8.3998-4007.1999","article-title":"Cloning, expression, and immunological evaluation of two putative secreted serine protease antigens of Mycobacterium tuberculosis","volume":"67","author":"Skeiky","year":"1999","journal-title":"Infect Immun"},{"key":"2022010901425794600_b12","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1084\/jem.191.3.551","article-title":"Expression cloning of an immunodominant family of Mycobacterium tuberculosis antigens using human CD4(+) T cells","volume":"191","author":"Alderson","year":"2000","journal-title":"J Exp Med"},{"key":"2022010901425794600_b13","doi-asserted-by":"crossref","first-page":"7140","DOI":"10.4049\/jimmunol.165.12.7140","article-title":"T cell expression cloning of a Mycobacterium tuberculosis gene encoding a protective antigen associated with the early control of infection","volume":"165","author":"Skeiky","year":"2000","journal-title":"J Immunol"},{"key":"2022010901425794600_b14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1146\/annurev.immunol.19.1.93","article-title":"Immunology of tuberculosis","volume":"19","author":"Flynn","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"2022010901425794600_b15","doi-asserted-by":"crossref","first-page":"343","DOI":"10.4049\/jimmunol.169.11.6343","article-title":"In vivo IL-10 production reactivates chronic pulmonary tuberculosis in C57BL\/6 mice","volume":"169","author":"Turner","year":"2002","journal-title":"J Immunol"},{"key":"2022010901425794600_b16","first-page":"255","article-title":"BCG induced CD4+ cytotoxic T cells from BCG-vaccinated healthy subjects: relation between cytotoxicity and suppression in vitro","volume":"69","author":"Mustafa","year":"1987","journal-title":"Clin Exp Immunol"},{"key":"2022010901425794600_b17","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/0264-410X(93)90070-E","article-title":"Long lasting T cell reactivity Mycobacterium leprae antigens in human volunteers vaccinated with killed M. leprae","volume":"11","author":"Mustafa","year":"1993","journal-title":"Vaccine"},{"key":"2022010901425794600_b18","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1046\/j.1365-3083.1998.00419.x","article-title":"Comparison of antigen specific T-cell responses of tuberculosis patients using complex or single antigens of Mycobacterium tuberculosis","volume":"48","author":"Mustafa","year":"1998","journal-title":"Scand J Immunol"},{"key":"2022010901425794600_b19","first-page":"364","article-title":"In vitro cellular and cytokine responses to mycobacterial antigens. Application to diagnosis to tuberculosis infection and assessment of response to mycobacterial vaccines","volume":"313","author":"Lein","year":"1997","journal-title":"Am J Med Sci"},{"key":"2022010901425794600_b20","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1128\/IAI.72.1.381-388.2004","article-title":"Immune responses to mycobacterial antigens in the Gambian population: implications for a vaccine and immunodiagnostic test design","volume":"72","author":"Vekemans","year":"2004","journal-title":"Infect Immun"},{"key":"2022010901425794600_b21","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1128\/IAI.71.4.1953-1960.2003","article-title":"Synthetic peptides identify promiscuous human Th1 cell epitopes of the secreted mycobacterial antigen MPB70","volume":"71","author":"Al-Attiyah","year":"2003","journal-title":"Infect Immun"},{"key":"2022010901425794600_b22","doi-asserted-by":"crossref","first-page":"7618","DOI":"10.4049\/jimmunol.172.12.7618","article-title":"Differential immune responses and protective efficacy induced by components of a tuberculosis polyprotein vaccine, Mtb72F, delivered as naked DNA or recombinant protein","volume":"172","author":"Skeiky","year":"2004","journal-title":"J Immunol"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2004.02609.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/138\/1\/139\/42082999\/j.1365-2249.2004.02609.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/138\/1\/139\/42082999\/j.1365-2249.2004.02609.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T09:44:49Z","timestamp":1682761489000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/138\/1\/139\/6439927"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8,31]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2004,8,31]]},"published-print":{"date-parts":[[2004,8,31]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.2004.02609.x","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[2004,10]]},"published":{"date-parts":[[2004,8,31]]}}}